How does it affect elab that it's new director is from qlgn

The appointment of a new director from Qualigen Therapeutics (QLGN) to the board of Elevai Labs Inc. (ELAB) could have several potential effects:

1. Bringing Expertise to ELAB: The new director, Orian Shirihai, MD, PhD, has extensive experience in the field of obesity and metabolism, with over 180 publications and multiple NIH-funded projects as a principal investigator. This expertise could be valuable to ELAB as it advances its scientific advisory board and potentially develops new skincare products or treatments.
2. Strengthening ELAB's Scientific Advisory Board: The appointment of Dr. Shirihai to ELAB's Scientific Advisory Board indicates a strengthening of the board's capabilities and expertise in the field of regenerative medicine and aesthetics. This could enhance ELAB's position in the medical aesthetics industry and its ability to develop innovative skincare products.
3. Potential for Collaboration: Although there is no direct indication of a collaboration between ELAB and QLGN, the shared focus on regenerative medicine and aesthetics could potentially lead to synergies and collaborations between the two companies. This could result in the development of new products or treatments that leverage the strengths of both companies.
4. Enhanced Credibility: The association of ELAB with a reputable figure like Dr. Shirihai could enhance its credibility in the scientific community and among investors. This could be particularly beneficial as ELAB continues to advance its clinical studies and products, such as the recently announced clinical study combining topical exosome skincare products with a medical aesthetic energy device.
5. Insider Knowledge and Perspective: The new director may bring insider knowledge and a unique perspective to ELAB's board, which could influence strategic decisions and help guide the company's growth and development.

In conclusion, the appointment of a new director from Qualigen Therapeutics to Elevai Labs Inc.'s board is likely to have a positive impact on ELAB. It brings expertise, strengthens the scientific advisory board, potentially opens doors for collaboration, enhances credibility, and provides a unique insider perspective that could shape the company's future strategies and achievements.